ArticleGeroScience2026
Adherence to the Mediterranean diet is associated with reduced risk of head and neck, gastric, and liver cancers: a systematic review and meta-analysis.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mediterranean diet (MedDiet) is well established for its cardiometabolic benefits and has increasingly been linked to reduced cancer risk. While protective associations with colorectal cancer are consistently reported, evidence for other gastrointestinal and upper aerodigestive malignancies remains less comprehensively synthesized. We conducted a systematic review and meta-analysis to quantify the association between adherence to the Mediterranean diet and the risk of head and neck, gastric, and liver cancers. A systematic search of PubMed, Web of Science, and Scopus was performed for observational studies published through September 2025. Prospective cohort and case-control studies reporting relative risk (RR), odds ratio (OR), or hazard ratio (HR) estimates comparing highest versus lowest MedDiet adherence were eligible. Pooled risk estimates were calculated using random-effects models. Thirty-four studies comprising 4,286,835 participants were included. High adherence to the Mediterranean diet was associated with significantly reduced risk of head and neck cancer (RR = 0.55; 95% CI = 0.45-0.67), gastric cancer (RR = 0.62; 95% CI = 0.53-0.73), and liver cancer (RR = 0.59; 95% CI = 0.53-0.67). Substantial heterogeneity was observed for head and neck (I
Indexed as
Identifiers
42744960What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.